Carregant...
Atovaquone: An antiprotozoal drug, suppresses primary and resistant breast tumor growth by inhibiting HER2/β-catenin signaling
Breast cancer is the second leading cause of cancer-related mortality in women. In the current study, we evaluated the anti-cancer effects of an anti-protozoal drug–atovaquone against several breast cancer cell lines. Our results showed that atovaquone treatment induced apoptosis and inhibited the g...
Guardat en:
| Publicat a: | Mol Cancer Ther |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6905100/ https://ncbi.nlm.nih.gov/pubmed/31270151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-18-1286 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|